LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/703975/Coronary-Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014
SummaryGlobalData's clinical trial report, "Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2
List of Tables 4List of Figures 5Introduction 6Coronary Arteriosclerosis 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 15Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Coronary Arteriosclerosis 25Subjects Recruited Over a Period of Time 26Clinical Trials by Sponsor Type 27Prominent Sponsors 28Top Companies Participating in Coronary Arteriosclerosis Therapeutics Clinical Trials 29Prominent Drugs 30Clinical Trial Profiles 31Clinical Trial Overview of Top Companies 31Pfizer Inc. 31Clinical Trial Overview of Pfizer Inc. 31Merck & Co., Inc. 32Clinical Trial Overview of Merck & Co., Inc. 32Eli Lilly and Company 33Clinical Trial Overview of Eli Lilly and Company 33Cytori Therapeutics, Inc. 34Clinical Trial Overview of Cytori Therapeutics, Inc. 34C. H. Boehringer Sohn AG & Co. KG 35Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35AstraZeneca PLC 36Clinical Trial Overview of AstraZeneca PLC 36MDDX LLC 37Clinical Trial Overview of MDDX LLC 37Innovaderm Research Inc. 38Clinical Trial Overview of Innovaderm Research Inc. 38CardioVascular BioTherapeutics, Inc. 39Clinical Trial Overview of CardioVascular BioTherapeutics, Inc. 39Avant Immunotherapeutics, Inc 40Clinical Trial Overview of Avant Immunotherapeutics, Inc 40Clinical Trial Overview of Top Institutes / Government 41National Heart, Lung, and Blood Institute 41Clinical Trial Overview of National Heart, Lung, and Blood Institute 41Providence VA Medical Center 42Clinical Trial Overview of Providence VA Medical Center 42National Taiwan University Hospital 43Clinical Trial Overview of National Taiwan University Hospital 43Seoul National University Hospital 44Clinical Trial Overview of Seoul National University Hospital 44Rigshospitalet 45Clinical Trial Overview of Rigshospitalet 45University of Ottawa Heart Institute 46Clinical Trial Overview of University of Ottawa Heart Institute 46University of California, San Diego 47Clinical Trial Overview of University of California, San Diego 47University of Minnesota 48Clinical Trial Overview of University of Minnesota 48Massachusetts General Hospital 49Clinical Trial Overview of Massachusetts General Hospital 49U.S. Department of Veterans Affairs 50Clinical Trial Overview of U.S. Department of Veterans Affairs 50Five Key Clinical Profiles 51Appendix 81Abbreviations 81Definitions 81Research Methodology 82Secondary Research 82About GlobalData 83Contact Us 83Disclaimer 83Source 83
List of TablesCoronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014* 7Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Coronary Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 31Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 32Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 33Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014* 34Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by MDDX LLC, 2014* 37Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014* 38Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2014* 39Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014* 40Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 41Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Providence VA Medical Center, 2014* 42Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 43Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 44Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 45Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 46Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 47Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 48Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 49Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 50
List of FiguresCoronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30GlobalData Methodology 82
Read the full report:Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014 https://www.reportbuyer.com/product/703975/Coronary-Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
Advertisement
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/703975/Coronary-Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html
Advertisement
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014
SummaryGlobalData's clinical trial report, "Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2
List of Tables 4List of Figures 5Introduction 6Coronary Arteriosclerosis 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 15Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Coronary Arteriosclerosis 25Subjects Recruited Over a Period of Time 26Clinical Trials by Sponsor Type 27Prominent Sponsors 28Top Companies Participating in Coronary Arteriosclerosis Therapeutics Clinical Trials 29Prominent Drugs 30Clinical Trial Profiles 31Clinical Trial Overview of Top Companies 31Pfizer Inc. 31Clinical Trial Overview of Pfizer Inc. 31Merck & Co., Inc. 32Clinical Trial Overview of Merck & Co., Inc. 32Eli Lilly and Company 33Clinical Trial Overview of Eli Lilly and Company 33Cytori Therapeutics, Inc. 34Clinical Trial Overview of Cytori Therapeutics, Inc. 34C. H. Boehringer Sohn AG & Co. KG 35Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35AstraZeneca PLC 36Clinical Trial Overview of AstraZeneca PLC 36MDDX LLC 37Clinical Trial Overview of MDDX LLC 37Innovaderm Research Inc. 38Clinical Trial Overview of Innovaderm Research Inc. 38CardioVascular BioTherapeutics, Inc. 39Clinical Trial Overview of CardioVascular BioTherapeutics, Inc. 39Avant Immunotherapeutics, Inc 40Clinical Trial Overview of Avant Immunotherapeutics, Inc 40Clinical Trial Overview of Top Institutes / Government 41National Heart, Lung, and Blood Institute 41Clinical Trial Overview of National Heart, Lung, and Blood Institute 41Providence VA Medical Center 42Clinical Trial Overview of Providence VA Medical Center 42National Taiwan University Hospital 43Clinical Trial Overview of National Taiwan University Hospital 43Seoul National University Hospital 44Clinical Trial Overview of Seoul National University Hospital 44Rigshospitalet 45Clinical Trial Overview of Rigshospitalet 45University of Ottawa Heart Institute 46Clinical Trial Overview of University of Ottawa Heart Institute 46University of California, San Diego 47Clinical Trial Overview of University of California, San Diego 47University of Minnesota 48Clinical Trial Overview of University of Minnesota 48Massachusetts General Hospital 49Clinical Trial Overview of Massachusetts General Hospital 49U.S. Department of Veterans Affairs 50Clinical Trial Overview of U.S. Department of Veterans Affairs 50Five Key Clinical Profiles 51Appendix 81Abbreviations 81Definitions 81Research Methodology 82Secondary Research 82About GlobalData 83Contact Us 83Disclaimer 83Source 83
List of TablesCoronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014* 7Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Coronary Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 31Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 32Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 33Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014* 34Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by MDDX LLC, 2014* 37Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014* 38Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2014* 39Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014* 40Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 41Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Providence VA Medical Center, 2014* 42Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 43Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 44Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 45Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 46Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 47Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 48Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 49Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 50
List of FiguresCoronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30GlobalData Methodology 82
Read the full report:Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014 https://www.reportbuyer.com/product/703975/Coronary-Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
